Genitourinary Cancers | Tumor

Nubeqa Plus ADT Outperformed ADT Alone in Treating Prostate Cancer

September 23rd 2024, 9:00pm

Article

Adding Nubeqa to androgen deprivation therapy improved radiographic progression-free survival in patients with metastatic hormone-sensitive prostate cancer.

Challenges to Consider While Receiving Fotivda for Kidney Cancer

September 21st 2024, 2:00pm

Video

At the 2024 ESMO Congress, CURE® spoke with an expert about Fotivda and certain challenges patients may experience, such as side effects.

Keytruda Improves Disease-Free Survival in Some With Urothelial Carcinoma

September 20th 2024, 7:00pm

Article

Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived without signs of cancer.

Swimsuit Model Reveals Ovarian Cancer, Hockey Pro Shares Diagnosis and More

September 20th 2024, 3:00pm

Article

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in the oncology space this week.

Survival Rate Increased With Yervoy-Opdivo Combo in Kidney Cancer

September 20th 2024, 1:00pm

Article

The 12-month survival rates in patients with non-clear cell renal cell carcinoma showed improvements after treatment with Yervoy plus Opdivo.

Trodelvy May Improve Responses in Bladder Cancer Subtype

September 18th 2024, 3:00pm

Article

Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed after checkpoint inhibitors.

Presurgical Cetrelimab With TAR-200 Shows Responses in Muscle-Invasive Bladder Cancer

September 16th 2024, 10:00pm

Article

Patients with muscle-invasive bladder cancer who were treated with presurgical chemotherapy may have a 55% lower risk of death, research shows.

Antibody-Drug Conjugate Is Tolerable, Active in CLDN6-Positive Solid Tumors Including Ovarian Cancer

September 15th 2024, 5:52pm

Article

Treatment with the antibody-drug conjugate TORL-1-23 was safe and tolerable in heavily pretreated, CLDN6-positive advanced solid tumors, including platinum-resistant ovarian cancer.

Welireg Shows Stable Survival Benefits Over Afinitor in Kidney Cancer

September 13th 2024, 9:00pm

Article

Among patients with previously treated advanced clear cell renal cell carcinoma (RCC) Welireg continued to show some benefits, though not to overall survival.

Princess Kate Finishes Chemo, E Street Band Member Announces Diagnosis and More

September 13th 2024, 3:00pm

Article

From Princess Kate entering ‘a new phase of recovery’ to a Rock and Roll Hall of Famer’s blood cancer announcement, here’s what’s happening in the cancer space this week.